Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Anthisan
2. Boots Bite And Sting Relief
3. Kriptin
4. Maleate, Mepyramine
5. Maleate, Pyrilamine
6. Mepyramine
7. Mepyramine Maleate
8. Pyranisamine
9. Pyrilamine
1. Mepyramine Maleate
2. 59-33-6
3. Histatex
4. Histan
5. Anisopyradamine
6. Histosol
7. Minihist
8. Pyrilamine Maleate Salt
9. Diaminide Maleate
10. Paraminyl Maleate
11. Antihist
12. Enrumay
13. Histine
14. Paramal
15. Pymafed
16. Pyraninyl
17. Renstamin
18. Pyramal Maleate
19. Stangen Maleate
20. Anthisan Maleate
21. Statomin Maleate
22. Thylogen Maleate
23. Pyra-maleate
24. Neoantergan Maleate
25. Pyranilamine Maleate
26. Pyranisamine Maleate
27. Neo-antergan Maleate
28. 2786 R.p. Maleate
29. Stamine
30. Neo-antergan
31. Nsc-3604
32. 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)pyridine Maleate (1:1)
33. Mls000069668
34. R35d29l3za
35. 1,2-ethanediamine, N-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, (z)-2-butenedioate (1:1)
36. Kriptin Maleate
37. Pyra Maleate
38. Prefrin A
39. Dorantamin Maleate
40. (z)-but-2-enedioic Acid;n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine
41. 1,2-ethanediamine,n-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-,(2z)-2-butenedioate (1:1)
42. Smr000058495
43. Histavet-p (veterinary)
44. (e)-but-2-enedioic Acid;n'-[(4-methoxyphenyl)methyl]-n,n-dimethyl-n'-pyridin-2-ylethane-1,2-diamine
45. N,n-dimethyl-n'-{[4-(methyloxy)phenyl]methyl}-n'-pyridin-2-ylethane-1,2-diamine (2z)-but-2-enedioate
46. Mepyramine Hydrogen Maleinate
47. Pyma
48. Histavet-p
49. Mepiramine Maleate
50. N1-(4-methoxybenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diamine Maleate
51. Component Of Pyrdex
52. Pymafed (tn)
53. Ccris 1330
54. Cas-59-33-6
55. Sr-01000000225
56. Nsc 3604
57. Einecs 200-422-7
58. Mfcd00069333
59. Pyrilamine Maleate (usp)
60. Component Of Endotussin-nn
61. Unii-r35d29l3za
62. N-dimethylaminoethyl-n-p-methoxy-alpha-aminopyridine Maleate
63. Pyrilamine Maleate [usan:usp]
64. N,n-dimethyl-n'-(4-methoxybenzyl)-n'-(2-pyridyl)ethylenediamine Maleate
65. N-p-methoxybenzyl-n',n'-dimethyl-n-alpha-pyridylethylenediamine Maleate
66. Prestwick_634
67. Opera_id_1702
68. 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine Bimaleate
69. Dsstox_cid_1216
70. P 5514
71. Pyridine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-, Maleate (1:1)
72. Dsstox_rid_76015
73. Dsstox_gsid_21216
74. Schembl27430
75. 1,2-ethanediamine, N-((4-methoxyphenyl)methyl)-n',n'-dimethyl-n-2-pyridinyl-, (2z)-2-butenedioate (1:1)
76. Mls001148634
77. Pyrilamine Maleate; Mepyramine
78. Spectrum1500519
79. Pyrilamine Maleate [mi]
80. Chembl1201006
81. Dtxsid4021216
82. Hms500i17
83. Nsc3604
84. Hms1568j20
85. Hms1920n10
86. Hms2092e11
87. Hms2095j20
88. Hms2234i23
89. Hms2234i24
90. Hms3262b22
91. Hms3411m20
92. Hms3675m20
93. Hms3712j20
94. Pharmakon1600-01500519
95. Pyrilamine Maleate [vandf]
96. Mepyramine Maleate [mart.]
97. Hy-b1281
98. Mepyramine Maleate [who-dd]
99. Pyrilamine Maleate [usp-rs]
100. Tox21_200514
101. Tox21_500890
102. 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine Maleate
103. Ccg-39244
104. N-(dimethylamino)ethyl-n-(p-methoxy)-.alpha.-aminopyridine Maleate
105. Nsc757305
106. S4382
107. Akos015950805
108. N-(p-methoxybenzyl)-n',n'-dimethyl-n-.alpha.-pyridylethylenediamine Maleate
109. Lp00890
110. Nsc-757305
111. Pyrilamine Maleate [green Book]
112. Pyrilamine Maleate [orange Book]
113. Mepyramine Maleate [ep Monograph]
114. Ncgc00094209-01
115. Ncgc00094209-02
116. Ncgc00094209-03
117. Ncgc00094209-04
118. Ncgc00094209-05
119. Ncgc00258068-01
120. Ncgc00261575-01
121. 1,2-ethanediamine, N1-((4-methoxyphenyl)methyl)-n2,n2-dimethyl-n1-2-pyridinyl-, (2z)-2-butenedioate (1:1)
122. Pyrilamine Maleate [usp Monograph]
123. Smr000653462
124. B6396
125. Cs-0013057
126. Eu-0100890
127. P2369
128. Prefrin-a Component Pyrilamine Maleate
129. D05660
130. Pyrilamine Maleate Component Of Prefrin-a
131. Wln: T6nj Bn1r Do1&2n1&1 &ov1u1vo
132. Sr-01000000225-2
133. Sr-01000000225-4
134. Sr-01000000225-5
135. Sr-01000000225-8
136. Q27287732
137. N-(p-methoxybenzyl)-n,2-ethanediamine, Maleic Acid Salt
138. 2-[(2-dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine Maleate
139. Mepyramine Maleate, European Pharmacopoeia (ep) Reference Standard
140. 2-[[2-(dimethylamino)ethyl]( P-methoxybenzyl)amino]pyridine Maleate (1:1)
141. Pyrilamine Maleate, United States Pharmacopeia (usp) Reference Standard
142. 1, N-[(4-methoxyphenyl)methyl]-n',n'-dimethyl-n-2-pyridinyl-, (z)-2-butenedioate (1:1)
143. N-(4-methoxyphenyl)methyl-n',n'-dimethyl-n-(2-pyridinyl)-1,2-ethanediamine Maleate
144. N1-(4-methoxybenzyl)-n2,n2-dimethyl-n1-(pyridin-2-yl)ethane-1,2-diaminemaleate
145. Pyrilamine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material
146. N-(4-methoxybenzyl)-n',n'-dimethyl-n-pyridin-2-ylethane-1,2-diamine (2z)-but-2-enedioate
Molecular Weight | 401.5 g/mol |
---|---|
Molecular Formula | C21H27N3O5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 9 |
Exact Mass | 401.19507097 g/mol |
Monoisotopic Mass | 401.19507097 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 396 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Sleep Aids, Pharmaceutical
Drugs used to induce SLEEP, prevent SLEEPLESSNESS, or treat SLEEP INITIATION AND MAINTENANCE DISORDERS. (See all compounds classified as Sleep Aids, Pharmaceutical.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Dosage Form : Syrup
Grade : Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Topical, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
Dosage Form : Softgels
Grade : Oral
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
19
PharmaCompass offers a list of Pyrilamine Maleate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pyrilamine Maleate manufacturer or Pyrilamine Maleate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrilamine Maleate manufacturer or Pyrilamine Maleate supplier.
PharmaCompass also assists you with knowing the Pyrilamine Maleate API Price utilized in the formulation of products. Pyrilamine Maleate API Price is not always fixed or binding as the Pyrilamine Maleate Price is obtained through a variety of data sources. The Pyrilamine Maleate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mepyramine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mepyramine, including repackagers and relabelers. The FDA regulates Mepyramine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mepyramine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mepyramine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mepyramine supplier is an individual or a company that provides Mepyramine active pharmaceutical ingredient (API) or Mepyramine finished formulations upon request. The Mepyramine suppliers may include Mepyramine API manufacturers, exporters, distributors and traders.
click here to find a list of Mepyramine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mepyramine DMF (Drug Master File) is a document detailing the whole manufacturing process of Mepyramine active pharmaceutical ingredient (API) in detail. Different forms of Mepyramine DMFs exist exist since differing nations have different regulations, such as Mepyramine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mepyramine DMF submitted to regulatory agencies in the US is known as a USDMF. Mepyramine USDMF includes data on Mepyramine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mepyramine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mepyramine suppliers with USDMF on PharmaCompass.
A Mepyramine CEP of the European Pharmacopoeia monograph is often referred to as a Mepyramine Certificate of Suitability (COS). The purpose of a Mepyramine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mepyramine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mepyramine to their clients by showing that a Mepyramine CEP has been issued for it. The manufacturer submits a Mepyramine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mepyramine CEP holder for the record. Additionally, the data presented in the Mepyramine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mepyramine DMF.
A Mepyramine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mepyramine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mepyramine suppliers with CEP (COS) on PharmaCompass.
A Mepyramine written confirmation (Mepyramine WC) is an official document issued by a regulatory agency to a Mepyramine manufacturer, verifying that the manufacturing facility of a Mepyramine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mepyramine APIs or Mepyramine finished pharmaceutical products to another nation, regulatory agencies frequently require a Mepyramine WC (written confirmation) as part of the regulatory process.
click here to find a list of Mepyramine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mepyramine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mepyramine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mepyramine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mepyramine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mepyramine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mepyramine suppliers with NDC on PharmaCompass.
Mepyramine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mepyramine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mepyramine GMP manufacturer or Mepyramine GMP API supplier for your needs.
A Mepyramine CoA (Certificate of Analysis) is a formal document that attests to Mepyramine's compliance with Mepyramine specifications and serves as a tool for batch-level quality control.
Mepyramine CoA mostly includes findings from lab analyses of a specific batch. For each Mepyramine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mepyramine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mepyramine EP), Mepyramine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mepyramine USP).